In vitro studies have shown that NLRX1, a mitochondrial PAMP, increases during viral infections, such as human immunodeficiency virus type 1 (HIV-1), resulting in increased oxidative phosphorylation and glycolysis. This evidence concerns the gene NLRX1 and viral infectious disease.